545 results on '"Contoli, Marco"'
Search Results
2. Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2
3. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
4. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
5. Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
6. Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients
7. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study
8. Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study
9. Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study
10. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
11. Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study
12. Beliefs and preferences regarding biological treatments for severe asthma
13. Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias
14. Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
15. SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia
16. Long-term healthcare resource and cost savings with allergy immunotherapy: REACT study results
17. Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients
18. Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up
19. ROX index on 3rd day as a best predictor of treatment failure in severe COVID-19 patients
20. Serum Ige levels and blood eosinophils as potential Th2 inflammation biomarkers and target to address Chronic Cough: a retrospective analysis
21. Evaluating as-needed inhaled corticosteroid strategies in asthma: Expanding the benefits to mild asthma
22. Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells
23. Update on virus-induced asthma exacerbations
24. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients
25. Long-term health care resource and cost savings with allergy immunotherapy: REACT study results
26. Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation
27. Withdrawal of inhaled corticosteroids in COPD: A meta-analysis
28. Asthma management in a specialist setting: Results of an Italian Respiratory Society survey
29. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy
30. Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history
31. High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
32. La gestione del paziente con rinosinusite cronica e poliposi nasale in Italia: expert opinion sul percorso diagnostico-terapeutico
33. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis
34. No patient is the same; lessons learned from antibody repertoire profiling in hospitalized severe COVID-19 patients
35. Sars-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
36. Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema
37. The Additional Value of Lower Respiratory Tract Sampling in the Diagnosis of COVID-19: A Real-Life Observational Study
38. Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
39. The impact of gender differences on pulmonary diseases and their clinical implications
40. Targeting Th2 Cells in Asthmatic Airways
41. Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease
42. Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation
43. Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence
44. Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection
45. Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma – Authors´ reply
46. Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)
47. Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life
48. Assessing and accessing the small airways; implications for asthma management
49. Additional file 1 of Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study
50. Update in Asthma 2016
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.